| P2093 | author name string | K Tanaka | |
| | K Harada | |
| | H Ito | |
| | K Miura | |
| | Y Kishimoto | |
| | K Nosaka | |
| | H Kawasaki | |
| | K Hori | |
| | N Noguchi | |
| | M Ishida | |
| | K Oyama | |
| | Y Takano | |
| | T Kanbe | |
| | A Hosoda | |
| | G Shiota | |
| | S Katayama | |
| | M Okubo | |
| | K Ashida | |
| | N Kaibara | |
| | O Tanida | |
| | H Kojo | |
| | T Suou | |
| | Y Tomie | |
| P2860 | cites work | A genetic model for colorectal tumorigenesis | Q27860582 |
| | p53 mutations in human cancers | Q28302973 |
| | p53 cellular tumor antigen: analysis of mRNA levels in normal adult tissues, embryos, and tumors | Q36895398 |
| | Immune response to p53 is dependent upon p53/HSP70 complexes in breast cancers | Q36954741 |
| | The p53 tumour suppressor gene | Q37751892 |
| | Multifactorial analysis of p53 alteration in human cancer: a review | Q40736226 |
| | Activating mutations in p53 produce a common conformational effect. A monoclonal antibody specific for the mutant form | Q41210647 |
| | Development of antibodies against p53 in lung cancer patients appears to be dependent on the type of p53 mutation | Q41612390 |
| | Antibodies against p53 are associated with poor prognosis of colorectal cancer | Q42590771 |
| | Expression of p53 protein in colorectal cancer and its relationship to short-term prognosis | Q44449506 |
| | Prognostic significance of circulating P53 antibodies in patients undergoing surgery for locoregional breast cancer. | Q44540976 |
| | Diagnosis and prognosis in colon cancer based on a profile in immune reactivity | Q44921675 |
| | The immune response to p53 in breast cancer patients is directed against immunodominant epitopes unrelated to the mutational hot spot | Q44950736 |
| | Detection of antibodies against the cellular protein p53 in sera from patients with breast cancer | Q45263174 |
| | Prognostic significance of serum anti-p53 antibody in patients with hepatocellular carcinoma. | Q50925177 |
| | Circulating antibodies against p53 protein in patients with ovarian carcinoma. Correlation with clinicopathologic features and survival. | Q53449605 |
| | Evidence that expression of a mutated p53 gene attenuates apoptotic cell death in human gastric intestinal-type carcinomas in vivo. | Q55362870 |
| | Association of p53 mutations with short survival in colorectal cancer | Q58409018 |
| | Analysis of p53 antibodies in patients with various cancers define B-cell epitopes of human p53: distribution on primary structure and exposure on protein surface | Q58409087 |
| | P53 expression in breast cancer | Q68125248 |
| | p53 immunostaining as a marker of malignant disease in diagnostic cytopathology | Q68311408 |
| | Presence of circulating antibodies against cellular protein p53 in a notable proportion of children with B-cell lymphoma | Q68928820 |
| | Expression of p53 gene in 184 unifocal hepatocellular carcinomas: association with tumor growth and invasiveness | Q70487570 |
| | Characterisation and clinicopathological correlates of serum anti-p53 antibodies in breast and colon cancer | Q71858034 |
| | The humoral immune response to p53 in patients with hepatocellular carcinoma is specific for malignancy and independent of the α-fetoprotein status | Q72092804 |
| | Prognostic significance of p53 expression in relation to DNA ploidy in colorectal adenocarcinoma | Q72731018 |
| P433 | issue | 1 | |
| P921 | main subject | colorectal cancer | Q188874 |
| | colorectal carcinoma | Q25493920 |
| P304 | page(s) | 122-128 | |
| P577 | publication date | 2000-01-01 | |
| P1433 | published in | Digestive Diseases and Sciences | Q15716711 |
| P1476 | title | Circulating p53 antibody in patients with colorectal cancer: relation to clinicopathologic features and survival | |
| P478 | volume | 45 | |